يعرض 2,061 - 2,080 نتائج من 7,231 نتيجة بحث عن '(( significant decrease decrease ) OR ( significantly reduced decrease ))~', وقت الاستعلام: 0.29s تنقيح النتائج
  1. 2061
  2. 2062
  3. 2063
  4. 2064
  5. 2065
  6. 2066

    Some examples of selected Chinese characters. حسب Weijia Zhu (65481)

    منشور في 2025
    "…Our model further integrates deep clipping and timestep optimization techniques, significantly reducing parameter complexity while maintaining superior performance. …"
  7. 2067

    Novel Small-Molecule miR-124 Inducer Acts as “a Physiological Brake” of Inflammation in Ulcerative Colitis by Targeting the PIK3R2/PI3K/Akt Axis حسب Tiantian Wang (1688881)

    منشور في 2025
    "…We found that FHND5032 significantly upregulated miR-124 expression in macrophages, surpassing the clinical-stage comparator ABX464 in vitro and in vivo. …"
  8. 2068

    Green Hydrogen Economy: Scenarios versus Technologies حسب Hua Fan (495346)

    منشور في 2025
    "…Our findings reveal that operational scenarios can reduce LCOH more significantly than technological improvements alone. …"
  9. 2069
  10. 2070

    Changes in the neutrophil count. حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  11. 2071

    Changes in the platelet count. حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  12. 2072

    Changes in the white blood cell count. حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  13. 2073

    Changes in the hemoglobin. حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  14. 2074

    WBC and ANC on day 7 post-chemotherapy. حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  15. 2075

    General clinical data of 88 patients with NPC. حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  16. 2076

    CONSORT participant flow diagram. حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  17. 2077

    S4 File - حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  18. 2078
  19. 2079
  20. 2080